Document is current
Any future updates will be listed below
-
Authors
Sakurai, Kotaro
Takeda, Chikashi
Tanaka-Mizuno, Sachiko
Mizota, Toshiyuki
Egi, Moritoki
Kawakami, Koji
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 5 June 2025
First Online: 30 June 2025
Declarations
:
: Koji Kawakami received research funds from Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Mitsubishi Corporation, OMRON Corporation, Real World Data Co., Ltd., Sumitomo Pharma Co., Ltd., and Toppan Inc.; consulting fees from Advanced Medical Care Inc., JMDC Inc., LEBER Inc., and Shin Nippon Biomedical Laboratories, Ltd.; executive compensation from Cancer Intelligence Care Systems, Inc.; honoraria from Chugai Pharmaceutical Co., Ltd., Kaken Pharmaceutical Co., Ltd., Mitsubishi Chemical Holdings Corporation, Mitsubishi Corporation, Pharma Business Academy, and Toppan Inc.; and held stock in Real World Data Co., Ltd.
